Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: VI Madrid Breast Cancer Conference: Changes in the treatment of breast cancer

Oral presentation

The role of Xeloda in metastasic breast cancer

H Cortés-Funes

  • Correspondence: H Cortés-Funes

Breast Cancer Research 2005, 7(Suppl 1):S26 doi:10.1186/bcr1230

No comments have yet been made on this article.

Post a comment